PRECLINICAL FEATURE ARTICLES
PRECLINICAL WHITE PAPERS & ARTICLES
-
![GettyImages-2036497698 clinical lab]( "The Evolving Landscape Of Radiopharmaceuticals In Oncology Research")
From selecting appropriate targeting molecules to optimizing dosing strategies and managing off-target effects, radiopharmaceutical development demands a tailored and strategic clinical approach.
-
![GettyImages-1471734234-derm-dermatology-skin]( "Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology")
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
-
![Bladder and Kidneys-GettyImages-1339092350]( "Bladder Cancer: Challenges And Innovations")
Bladder cancer ranks ninth in incidence and 13th in mortality among cancers. Recent advancements in treatment are transforming the management of advanced bladder cancer cases.
-
![GettyImages-1067806130_lab rat]( "Safety Assessment For Ophthalmic Products")
Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.
-
![GettyImages-820772090 eyes]( "Comprehensive Services For Ophthalmic Drug Development")
To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.
PRECLINICAL APPLICATIONS & STUDIES
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study4/17/2025
This randomized controlled pivotal phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for 3 consecutive weeks pre-surgery.
-
LC-MS/MS Method Development Of Endogenous Small Molecule Biomarker1/17/2025
Biomarkers are essential to improve drug R&D efficiency. Explore some practical solutions for achieving a fit-for-purpose LC-MS/MS biomarker analysis method.
-
Drug Development Program Management10/28/2024
Learn how a consultant helped a biotech company specializing in immuno-oncology to develop timeline reports for the product and portfolio and identify and address gaps in the filing plan.
-
A Versatile Application For Rapid Mass Confirmation And Purity Assessment Of Biotherapeutics7/18/2022
We explore a streamlined integrated workflow for data acquisition, processing and reporting of deconvoluted mass data for biotherapeutics, deployable in regulated and non-regulated environments.
-
Transferring N-Glycan HILIC Separations Between UPLC And HPLC7/18/2022
We demonstrate that comparable chromatographic profiles and relative quantitation can be achieved with the larger particle size column at HPLC-compatible pressures, albeit with an increase in sample load, mobile phase use, and most importantly, analysis time.
PRECLINICAL PRODUCTS & SERVICES
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
PRECLINICAL SOLUTIONS
PRECLINICAL SUPPLIERS
-
![SAE / ADR / MDR Management]( "PRA Health Sciences")
PRA is a global Clinical Research Organization providing services through all phases of clinical development. PRA has supported over 3,100 clinical trials in more than 80 countries on 6 continents through our global offices. PRA's therapeutic expertise, global reach, and project experience with local knowledge enable our project teams to deliver consistent and on time performance for our clients.
-
![MPI Research]( "MPI Research")
MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries.
PRECLINICAL & CLINICAL TRIAL NEWS
- Harlan Laboratories Continues Global Growth With Major Expansion Of North American Facilities
- La Jolla Pharmaceutical Company Announces Completion Of Phase 1 Portion Of GCS-100 Clinical Trial In Chronic Kidney Disease
- DSM And DecImmune Therapeutics Sign Agreement To Develop N2 Pathway Blocking Antibody
- Catabasis Initiates Phase 1 Trial Of CAT-2003 For Treatment Of Severe Hypertriglyceridemia
- Spanish Biotech PharmaMar Selects Medidata Clinical Cloud To Accelerate Trials For Marine-Based Oncology Drugs
- Cubist Announces Exclusive Option To Acquire Adynxx
- The Michael J. Fox Foundation Launches New Funding Opportunities For Parkinson's Research
- Ability Pharmaceuticals Awarded A 1.2 Million Euros Grant To Develop Its Lipid Analog ABTL0812 For Lung And Pancreatic Cancer
- Reaxys® Medicinal Chemistry Provided As Part Of Elsevier's Suite Of Life Science
- DiaMedica Successfully Completes DM-199 cGMP Manufacturing And Pre-Clinical Toxicology Safety Studies
- Savant HWP Announces NIDA Funding For Pre-Clinical Development Of 18-MC As Potential Treatment For Addiction, Obesity
- Bio-Matrix' Regen BioPharma Initiates Pre-Clinical Study In Support Of HemaXellerate™ Cell Therapy
- ClinicalRM Awarded Contract For Regulatory, Clinical And Technical Services To Support The U.S. Army Medical Materiel Development Activity (USAMMDA)
- Accelovance Strengthens Executive Team With Chief Medical Officer